| Serial Number | 97111780 |
| Word Mark | MARENGO |
| Filing Date | Friday, November 5, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Friday, May 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 20, 2022 |
| Goods and Services | Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations |
| Goods and Services | Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicines |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 16, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 16, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MARENGO THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | MARENGO THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Tuesday, November 9, 2021 | NEW APPLICATION ENTERED |
| Tuesday, November 16, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 16, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, August 16, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 31, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 20, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 20, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 21, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 15, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 15, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, May 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 15, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, October 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 17, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, October 17, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, October 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 3, 2024 | SOU EXTENSION 3 GRANTED |
| Friday, May 3, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 3, 2024 | SOU EXTENSION 3 FILED |
| Saturday, May 4, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 17, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |